Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term intra-articular hyaluronan versus corticosteroid in hip osteoarthritis
NL-OMON34660Phase 4Withdrawn
- Sponsor
- Medisch Centrum Leeuwarden
- Start
- Sep 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium hyaluronate, methylprednisolone and lidocaine in hip osteoarthritis, sponsored by Medisch Centrum Leeuwarden. Planned start Sep 2010; status: withdrawn.
02
Drugs
sodium hyaluronatemethylprednisolonelidocaine
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on NL-OMON34660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34660.